UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000003855
Receipt number R000004625
Scientific Title Phase II study of cisplatin, pemetrexed plus bevacizumab for EGFR mutation negative or unknown stage III/IV non-small-cell lung cancer (non-squamous cell lung cancer)
Date of disclosure of the study information 2010/07/01
Last modified on 2013/03/13 14:53:22

No. Disposal Last modified on Item of update
1 Insert 2010/07/01 19:07:19
2 Update 2010/08/02 16:32:54 Interventions/Control_1
3 Update 2013/03/13 14:53:22 Recruitment status